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Background
Systematic reviews are hampered by inconsistencies in
outcomes assessed and reported in otherwise eligible
studies. Many meta-analyses have to exclude key studies
because relevant outcomes were not reported. Much
could be gained if an agreed minimum set of appropri-
ate and important outcomes was measured and reported
in all clinical trials in a particular area.
Why standardise outcomes?
The design of new trials would be simplified, the risk
of measuring inappropriate outcomes would be
reduced, and selective reporting of outcomes less
likely. It would be easier to compare, contrast and
combine studies in systematic reviews. Core outcome
sets would help review authors to present their find-
ings clearly and succinctly, for example within Sum-
mary of Findings tables.
Aims of the COMET Initiative
The COMET Initiative brings together researchers inter-
ested in core outcome sets, with well attended interna-
tional meetings held in 2010 and 2011. COMET aims to
foster and facilitate research by providing guidance on
developing a core outcome set, methods to include user
involvement in this process, and preparing reporting
standards for such projects. Further information about
C O M E Tc a nb ef o u n da t[ h t t p : / / www.comet-initiative.
org]. Work is ongoing to identify, collate and maintain
relevant resources in an on-line searchable database
[http://www.comet-initiative.org/studies/search]. More
than 50 completed projects in various areas of health/
health care have been identified. Several examples of
planned and ongoing work have also been recorded.
The COMET database will be demonstrated and pro-
gress to date presented.
Implications
If successful, COMET will help trialists to choose out-
comes, and will therefore increase the likelihood that
these outcomes will be measured, thereby decreasing
the likelihood of important studies being excluded from
systematic reviews. By improving the evidence base,
COMET will make it easier for people to make well-
informed decisions about health care.
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